Sagimet Biosciences (SGMT) Invested Capital (2023 - 2024)
Historic Invested Capital for Sagimet Biosciences (SGMT) over the last 2 years, with Q3 2024 value amounting to $170.7 million.
- Sagimet Biosciences' Invested Capital rose 7438.88% to $170.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $170.7 million, marking a year-over-year increase of 7438.88%. This contributed to the annual value of $91.1 million for FY2023, which is N/A changed from last year.
- As of Q3 2024, Sagimet Biosciences' Invested Capital stood at $170.7 million, which was up 7438.88% from $183.3 million recorded in Q2 2024.
- Sagimet Biosciences' 5-year Invested Capital high stood at $190.0 million for Q1 2024, and its period low was -$198.4 million during Q2 2023.